GSK - International Biopharmaceutical Industry

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Subsection - Oncology

Essential DMPK Strategies for IND Success

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

news

Early tests suggest Vir, GSK antibody could hold up versus omicron

Omicron's detection last week triggered travel restrictions and renewed public health measures around the world as scientists and government officials warned the vari...

3 December 2021 news Antibody | GSK

Continue Reading →

news

Pfizer, marking fast research pace, starts key trial of RSV vaccine

A vaccine against RSV has proven elusive despite decades of attempts. Pfizer is moving at a surprisingly quick pace to catch up to rivals led by GlaxoSmithKline, who ...

3 September 2021 news GlaxoSmithKline | GSK

Continue Reading →

news

GSK, in race to catch up with rivals, wins expanded approval for cancer drug

GSK has high hopes for Jemperli as it transitions to what's being called the "new GSK," with a greater focus on experimental drugs for infectious disease, cancer and ...